DNAtoUSA
DNAtoUSA
Sex: M
Data Quality: 0 stars
Parkinson's: 10 yrs
Hoehn-Yahr 2 Type: Parkinson's disease On
Mouth/throat: none
Arms: mild
Chest: none
Legs: mild
DNAtoUSA
Male, 58 years
Denver, CO
Primary Condition
Parkinson's
Type
Parkinson's disease
First symptom
Jan 2002
Diagnosis
Oct 2007
See more

Treatment charts require Flash. If you have problems installing Flash, visit the FAQ for help.

Get Adobe Flash player

DNAtoUSA's Carbidopa-Levodopa CR is for:

  • Parkinson's

DNAtoUSA has not reported any side effects for Carbidopa-Levodopa CR.

DNAtoUSA's Carbidopa-Levodopa CR History (Ongoing)
25 mg-100 mg Daily Feb 02, 2010 - Last Update
Evaluations
Date Dosage Parkinson's Disease Efficacy Side Effects Adherence Burden
Mar 16, 2010 25 mg-100 mg Daily Led_efficacy_4Led_efficacy_4Led_efficacy_4Led_efficacy_4 NoneNoneNoneNone UsuallyUsuallyUsuallyUsually Not at allNot at allNot at allNot at all

About Carbidopa-Levodopa CR (Prescription Drug)

A controlled release preparation of carbidopa/levodopa formulated to release a lower, smoother dose of medication. It is sometimes taken last thing at night in order to maintain dopamine levels throughout sleep and into the morning.

Learn more about Carbidopa-Levodopa CR in our Carbidopa-Levodopa CR Community Report.

Back to DNAtoUSA's Profile